Fasten your seatbelts, traders. Friday’s Nifty session looked calm on the surface, eking out a quiet 94-point gain within a muted 120-point daily range. However, on the macro timeframe, a historically rare structural explosion has just taken place. By the time the closing bell rang to end July, Nifty not only broke a massive 8-month… Read More »
As the curtain closes on July, Bank Nifty is displaying one of the rarest and most explosive price compression setups a trader can witness. Friday’s session closed up by 130 points, but it was suffocated within an ultra-tight daily range of just 215 points. Beneath this calm, a “mother of all breakouts” is brewing. With Bank… Read More »
Market structure changes dictate execution strategy. The exchange has fundamentally altered the end-of-day trading mechanics for specific equities, shifting from standard continuous matching up to 3:30 PM to a structured Closing Auction Session (CAS). For active traders, understanding these micro-structural changes is critical. If you are trading CAS-eligible stocks, the traditional rules of engagement in… Read More »
It was the season’s first torrential downpour. The streets had turned into rivulets, and the relentless rain blurred the world into a hazy watercolor painting. Standing drenched in that merciless rain, outside a modest, unassuming house, was a newlywed bride clutching her dripping dupatta, her teeth chattering slightly. “Is… is this the place?” Riddhima asked, her… Read More »
Executive Summary: The Headline Strong recovery quarter: Consolidated Revenue +23% YoY to ₹4,018 Cr. PAT surged to ₹483 Cr (vs ₹47 Cr YoY — multi-fold jump). EBITDA +39% YoY to ₹805 Cr with margin expansion to 20%. Broad-based growth: India Formulations +15.5%, North America and Europe also contributed positively. Overarching narrative: Glenmark delivered a robust… Read More »
Executive Summary: The Headline Solid top-line and reported profit growth: Revenue +10.5% YoY to ₹15,300 Cr. Reported PAT +27% YoY to ₹2,895 Cr. Adjusted PAT +3.1% to ₹3,089 Cr. India and Specialty drove performance: India Formulations grew 16% YoY. Global Innovative Medicines grew 12.8%. US Formulations declined. Overarching narrative: A steady quarter for India’s largest… Read More »
Executive Summary: The Headline Exceptional profitability surge: Consolidated PAT nearly doubled (+97% YoY) to ₹4,665–4,671 Cr. Revenue +17% YoY to ₹41,350 Cr. Gas Marketing drove the beat: Natural Gas Marketing PBIT more than tripled, becoming the primary earnings engine. Transmission remained stable, while Petrochemicals stayed weak. Overarching narrative: A strong quarter for GAIL, powered by… Read More »
Market Date Analysis: July 30, 2026Nifty 50 CMP (Closing Price): 24,296 The expiry is behind us, and we are now stepping into the new series with a massively important trading session. Today is all about the Weekly and Monthly Close, and it has the power to dictate the structural market trend for the entirety of August. While yesterday’s… Read More »
As we head into the high-stakes monthly expiry session, Bank Nifty is displaying classic signs of a coiled spring. Yesterday’s session saw tight consolidation, closing merely 49 points lower inside a 425-point daily range. The advance/decline breadth was exceptionally weak (03:11), but looking at the bigger macro picture and underlying derivative positions, an aggressive directional move is… Read More »
Executive Summary: The Headline Healthy double-digit growth: Revenue +18% YoY to ₹5,528 Cr. PAT +28% YoY to ₹351 Cr. EBITDA +15.5% YoY to ₹621 Cr. Broad-based strength: Automotive OEM business grew >25% for the third consecutive quarter. Replacement, Industrial, Inverter, and Solar segments also delivered double-digit growth. Overarching narrative: A solid start to FY27 for… Read More »